What is the enterprise number of JL PHARMA?

The enterprise number of JL PHARMA is BE0743926553.

What is the address of JL PHARMA?

The registered office of JL PHARMA is located at Chession 32, 4987 Stoumont.

When was JL PHARMA founded?

JL PHARMA was founded on 20 February 2020.

What is the main activity of JL PHARMA?

The main activity of JL PHARMA is "Detailhandel in farmaceutische producten" (NACE code 47730).

Does JL PHARMA have a website?

No website is currently known for JL PHARMA.

How much profit did JL PHARMA make in 2025?

JL PHARMA posted a profit after taxes of € 5,740 in financial year 2025.

What is the revenue of JL PHARMA?

As a small company, JL PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 15,096.

Where can I find the annual accounts of JL PHARMA?

JL PHARMA files its annual accounts with the Central Balance Sheet Office of the National Bank of Belgium. The key figures for recent financial years are available for free on this page.

Who are the directors of JL PHARMA?

According to the 2025 annual accounts, the directors of JL PHARMA are: Jacqueline Lenain.

JL PHARMA (Private Limited) - Stoumont (4987) - BE0743926553

Financials

Financial year 2025

Gross margin

€ 15,096

▲ 2% vs 2024

Profit

Growing

€ 5,740

▲ 60% vs 2024

Debts

Low

€ 11,861

▼ 35% vs 2024

JL PHARMA from Stoumont, company number BE0743926553, closed financial year 2025 with a result of € 5,740 after tax. For that financial year JL PHARMA recorded a gross margin of € 15,096 and equity of € 10,746. Compared with financial year 2024, the result moved from € 3,595 to € 5,740. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 18, 2026.

What happened at JL PHARMA?

What happened at JL PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 18, 2026 New annual accounts for financial year 2025: profit of € 5,740 (▲ 60% vs 2024). Source: NBB ↗
Mar 1, 2020 New establishment in Stoumont. KBO
2020 Jacqueline Lenain became a director. NBB
Feb 20, 2020 Start of the company according to the CBE. KBO

In short

From € 7,135 profit in 2021 to € 5,740 profit in 2025.

Paid € 12,683 in corporate taxes since 2021.

Best year ever: 2021, with € 7,135 profit.

Paid out € 25,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at JL PHARMA? We notify you, reason included.

Follow JL PHARMA

Need more data?

History

Every financial year, as far back as the National Bank goes.

Buffer

How long does the company survive without income?

Credit limit

Indicative credit limit, computed from the real figures.

Alerts

New annual account: profit halved. New

Gazette: capital increase of 250k. New

News about who you follow, reason included.

Databakkes Pro · first month free

Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.

Management

Jacqueline Lenain

JL PHARMA

Behind JL PHARMA is Jacqueline Lenain.

See the full network in the app

Directors

According to the 2025 annual accounts

Jacqueline Lenain

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Chession 32

4987 Stoumont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0743.926.553
VAT number: BE 0743.926.553
Registered office: Chession 32, 4987 Stoumont
Names & denominations: JL PHARMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 20 February 2020
Peppol: Active · Active since 18 Dec 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗